Hov, Johannes R. http://orcid.org/0000-0002-5900-8096
Karlsen, Tom H. http://orcid.org/0000-0002-8289-9931
Article History
Accepted: 13 September 2022
First Online: 9 November 2022
Competing interests
: J.R.H. reports speaker fees from Roche, Novartis and Amgen, consultancy fees from Novartis and Orkla Health, and research funding from Biogen, all unrelated to the present work. T.H.K. reports speaker fees from AlfaSigma, and consultancy fees from Intercept, Gilead and Albireo, all unrelated to the present work.